{"id":"https://openalex.org/W2074577394","doi":"https://doi.org/10.1093/neuonc/nou314","title":"Factorial clinical trials: a new approach to phase II neuro-oncology studies","display_name":"Factorial clinical trials: a new approach to phase II neuro-oncology studies","publication_year":2014,"publication_date":"2014-12-01","ids":{"openalex":"https://openalex.org/W2074577394","doi":"https://doi.org/10.1093/neuonc/nou314","mag":"2074577394","pmid":"https://pubmed.ncbi.nlm.nih.gov/25452393","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4288526"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/nou314","doi":"https://doi.org/10.1093/neuonc/nou314","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nou314","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4288526","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087754052","display_name":"FABIO MASSAITI IWAMOTO","orcid":"https://orcid.org/0000-0003-1397-9927","observed_orcids":["https://orcid.org/0000-0003-1397-9927"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. M. Iwamoto","raw_affiliation_strings":["Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057541817","display_name":"Andrew B. Lassman","orcid":"https://orcid.org/0000-0001-7386-9928","observed_orcids":["https://orcid.org/0000-0001-7386-9928"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. B. Lassman","raw_affiliation_strings":["Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"2","first_page":"174","last_page":"176"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.051600001752376556,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11798","display_name":"Optimal Experimental Design Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1803","display_name":"Management Science and Operations Research"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4050000011920929},{"id":"https://openalex.org/keywords/drug-screening","display_name":"drug screening","score":0.5329999923706055},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.7429999709129333},{"id":"https://openalex.org/keywords/cilengitide","display_name":"cilengitide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.7749999761581421}],"concepts":[{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5367236137390137},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5164709091186523},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4927976429462433},{"id":"https://openalex.org/C2776598537","wikidata":"https://www.wikidata.org/wiki/Q1812651","display_name":"Clinical Oncology","level":3,"score":0.4498806893825531},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4448031187057495},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.10981693863868713}],"mesh":[{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015474","descriptor_name":"Isotretinoin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1093/neuonc/nou314","doi":"https://doi.org/10.1093/neuonc/nou314","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/nou314","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4288526","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4288526","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"},{"id":"pmid:25452393","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25452393","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-oncology","raw_type":"Editorial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1010.1025","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1010.1025","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://neuro-oncology.oxfordjournals.org/content/17/2/174.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1022.8640","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1022.8640","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://neuro-oncology.oxfordjournals.org/content/early/2014/12/01/neuonc.nou314.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4288526","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4288526","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2793661665","display_name":"Columbia University Minority/Underserved Site NCI Community Oncology Research Program","funder_award_id":"UG1CA189960","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000916142","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA013696","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W1549228047","https://openalex.org/W1664099944","https://openalex.org/W2005295476","https://openalex.org/W2050560655","https://openalex.org/W2070727225","https://openalex.org/W2096287682","https://openalex.org/W2101922439","https://openalex.org/W2120289860","https://openalex.org/W2124736921","https://openalex.org/W2148977460","https://openalex.org/W2156330848","https://openalex.org/W2158767537","https://openalex.org/W2159331778"],"related_works":["https://openalex.org/W7095768484","https://openalex.org/W7095652659","https://openalex.org/W2262545071","https://openalex.org/W2162193371","https://openalex.org/W2316613693","https://openalex.org/W2511436902","https://openalex.org/W2604818452","https://openalex.org/W2155255419","https://openalex.org/W2108301172","https://openalex.org/W2289567278"],"abstract_inverted_index":{"Glioblastoma":[0],"(GBM)":[1],"is":[2,132],"the":[3,38,95,103,120,127],"most":[4],"common":[5],"and":[6,25,28,102],"aggressive":[7],"primary":[8],"brain":[9],"tumor":[10],"in":[11,86,119],"adults.1":[12],"Standard":[13],"initial":[14],"treatment":[15],"consists":[16],"of":[17,34,40],"max-imal":[18],"surgical":[19],"resection":[20],"followed":[21],"by":[22],"concurrent":[23],"radiotherapy":[24],"temozolomide":[26,36],"chemotherapy":[27],"then":[29],"at":[30],"least":[31],"six":[32],"months":[33],"ad-juvant":[35],"(in":[37],"absence":[39],"disease":[41],"progression":[42],"or":[43],"un-acceptable":[44],"toxicity).2":[45],"However,":[46],"nearly":[47,81],"all":[48,82],"tumors":[49],"eventually":[50],"recur,":[51],"ultimately":[52],"leading":[53],"to":[54,113,129],"death":[55],"within":[56],"1\u20132":[57],"years":[58],"from":[59],"diagnosis.2":[60],"In-numerable":[61],"clinical":[62],"trials":[63],"have":[64],"tested":[65,85],"new":[66],"agents,":[67],"each":[68],"with":[69],"prom-ising":[70],"pre-clinical":[71],"data.":[72],"Some":[73],"demonstrated":[74],"encouraging":[75],"phase":[76,89,121],"II":[77,122],"efficacy":[78,117],"results,":[79],"but":[80],"failed":[83],"when":[84],"a":[87],"randomized":[88],"III":[90],"context.":[91],"Recent":[92],"examples":[93],"include":[94],"vascular":[96],"endothe-lial":[97],"growth":[98],"factor":[99],"inhibitor":[100],"bevacizumab3,4":[101],"integrin":[104],"inhibi-tor":[105],"cilengitide5":[106],"for":[107,116],"newly":[108],"diagnosed":[109],"GBM.":[110],"New":[111],"approaches":[112],"screen":[114],"drugs":[115],"rapidly":[118],"setting":[123],"are":[124],"needed.":[125],"Simultaneously,":[126],"need":[128],"combine":[130],"agents":[131],"pressing":[133]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}